Why Amarin's Stock Is Trading Higher Today

Amarin Corp AMRN shares are trading higher on Wednesday after Piper Sandler initiated coverage on the company's stock with an Overweight rating and announced a $21 price target.

Amarin is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its products include Vascepa.

Amarin shares were trading up 6.59% at $7.12 on Wednesday during the time of publication. The stock has a 52-week high of $26.12 and a 52-week low of $3.95.

Related Links:

Verastem Shares Response Rate From COPIKTRA Data

FDA Approves Edesa's Dermatitis Treatment Study, Shares Up More Than 100%

Loading...
Loading...
AMRN Logo
AMRNAmarin Corp PLC
$10.18-1.40%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
21.75
Growth
3.09
Quality
-
Value
91.58
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Comments
Loading...